These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31746243)

  • 1. Nanoparticles for antiparasitic drug delivery.
    Sun Y; Chen D; Pan Y; Qu W; Hao H; Wang X; Liu Z; Xie S
    Drug Deliv; 2019 Dec; 26(1):1206-1221. PubMed ID: 31746243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.
    Kayser O; Olbrich C; Croft SL; Kiderlen AF
    Parasitol Res; 2003 Jun; 90 Suppl 2():S63-70. PubMed ID: 12937968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.
    Date AA; Joshi MD; Patravale VB
    Adv Drug Deliv Rev; 2007 Jul; 59(6):505-21. PubMed ID: 17574295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release from nanocarriers: a review.
    Natarajan JV; Nugraha C; Ng XW; Venkatraman S
    J Control Release; 2014 Nov; 193():122-38. PubMed ID: 24862321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents.
    Xie S; Tao Y; Pan Y; Qu W; Cheng G; Huang L; Chen D; Wang X; Liu Z; Yuan Z
    J Control Release; 2014 Aug; 187():101-17. PubMed ID: 24878179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers for Effective Brain Drug Delivery.
    Comoglu T; Arisoy S; Akkus ZB
    Curr Top Med Chem; 2017; 17(13):1490-1506. PubMed ID: 28017157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterials as a Potential Target for Infectious Parasitic Agents.
    Alsharedeh RH; Rezigue M; Bashatwah RM; Amawi H; Aljabali AAA; Obeid MA; Tambuwala MM
    Curr Drug Deliv; 2024; 21(6):828-851. PubMed ID: 36815647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoformulations of albendazole as effective anticancer and antiparasite agents.
    Movahedi F; Li L; Gu W; Xu ZP
    Nanomedicine (Lond); 2017 Oct; 12(20):2555-2574. PubMed ID: 28954575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material.
    Li W; Zhang T; Ye Y; Zhang X; Wu B
    Int J Pharm; 2015 Nov; 495(2):948-55. PubMed ID: 26453780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation.
    Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues.
    Wang L; Zhou Y; Wu M; Wu M; Li X; Gong X; Chang J; Zhang X
    Nanomedicine (Lond); 2018 Jan; 13(1):69-88. PubMed ID: 29173025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents.
    Taghipour-Sabzevar V; Sharifi T; Moghaddam MM
    Ther Deliv; 2019 Aug; 10(8):527-550. PubMed ID: 31496433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release.
    Tang Q; Yu B; Gao L; Cong H; Song N; Lu C
    Curr Med Chem; 2018; 25(16):1837-1866. PubMed ID: 29332566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.